Phase II study of biweekly paclitaxel plus infusional 5-fluorouracil and leucovorin as first-line chemotherapy in patients with advanced gastric cancer

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 34, Issue 4, 2011, Pages 401-405

  Wang, Fenghua ^a,b   Wang, Zhiqiang ^a,b   Zhou, Ningning ^a,b   An, Xin ^a,b   Xu, Ruihua ^a,b   He, Youjian ^a,b   Li, Yuhong ^a,b  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

5 fluorouracil; advanced gastric cancer; leucovorin; paclitaxel

Indexed keywords

CAPECITABINE; CIMETIDINE; DEXAMETHASONE; DIPHENHYDRAMINE; FLUOROURACIL; FOLINIC ACID; PACLITAXEL;

ADULT; ADVANCED CANCER; AGED; ALOPECIA; ANEMIA; ANOREXIA; ARTHRALGIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; CONTINUOUS INFUSION; DIARRHEA; DRUG EFFICACY; DRUG TOLERABILITY; FATIGUE; FEMALE; HAND FOOT SYNDROME; HISTOLOGY; HUMAN; HYPERSENSITIVITY; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; MYALGIA; NAUSEA AND VOMITING; NEUROPATHY; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; REPEAT PROCEDURE; STOMACH CANCER; STOMATITIS; THERAPY DELAY; THROMBOCYTOPENIA; TREATMENT RESPONSE; VEIN THROMBOSIS;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SIGNET RING CELL; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; LEUCOVORIN; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PACLITAXEL; PERITONEAL NEOPLASMS; SKIN NEOPLASMS; STOMACH NEOPLASMS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 79961135225     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e3181e84b63     Document Type: Article

References (25)

1. Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol. 2006;12:354-362. (Pubitemid 43329250)
2. Yang L, Parkin DM, Whelan S, et al. Statistics on cancer in China: Cancer registration in 2002. Eur J Cancer Prev. 2005;14:329-335. (Pubitemid 41104940)
3. Sastre J, García-Saenz JA, Díaz-Rubio E. Chemotherapy for gastric cancer. World J Gastroenterol. 2006;12:204-213. (Pubitemid 43347879)
4. Meta-Analysis Group in Cancer. Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. J Clin Oncol. 1998;16:301-308.
5. Meta-Analysis Group in Cancer. Toxicity of fluorouracil in patients with advanced colorectal cancer: Effect of administration schedule and prognostic factors. J Clin Oncol. 1998;16:3537-3541.
6. Meta-Analysis Group in Cancer. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: An updated meta-analysis. J Clin Oncol. 2004;22:3766-3775.
7. Chang YF, Li LL, Wu CW, et al. Paclitaxel-induced apoptosis in human gastric carcinoma cell lines. Cancer. 1996;77:14-18. (Pubitemid 26002731)
8. Ajani JA, Fairweather J, Dumas P, et al. Phase II study of Taxol in patients with advanced gastric carcinoma. Cancer J Sci Am. 1998;4:269-274.
9. Yamada Y, Shirao K, Ohtsu A, et al. Phase II trial of paclitaxel by 3-hour infusion for advanced gastric cancer with short premedication for prophylaxis against paclitaxel-associated hypersensitivity reactions. Ann Oncol. 2001;12: 1133-1137. (Pubitemid 32834495)
10. Yamaguchi K, Tada M, Horikoshi N, et al. Paclitaxel Gastric Cancer Study Group in Japan. Phase II study of paclitaxel with 3-h infusion in patients with advanced gastric cancer. Gastric Cancer. 2002;5:90-95. (Pubitemid 34832243)
11. Kano Y, Akutsu M, Tsunoda S, et al. Schedule-dependent interation between paclitaxel and 5-fluorouracil in human carcinoma cell lines in vitro. Br J Cancer. 1996;74:704-710. (Pubitemid 26300760)
12. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst. 2000;92:205-216. (Pubitemid 30099779)
13. Fernando Rivera, Eugenia Vega-Villegas M, Marta F, et al. Chemotherapy of advanced gastric cancer. Cancer Treat Rev. 2007;33:315-324.
14. Roth AD, Fazio N, Stupp R, et al. Docetaxel, cisplatin, and fluorouracil; docetaxel and cisplatin; and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma: A randomized phase II trial of the Swiss Group for Clinical Cancer Research. J Clin Oncol. 2007;25:3217-3223. (Pubitemid 47325604)
15. Ajani JA, Fodor MB, Tjulandin SA, et al. Phase II trial of docetaxel plus cisplatin with or without fluorouracil in patients with untreated, advanced gastric, or gastroesophageal adenocarcinoma. J Clin Oncol. 2005;23:5660-5667.
16. Van cutsem E, Moiseyenko VM, Tjulandin S, et al. Phase III study of docetaxel and cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: A report of the V325 Study Group. J Clin Oncol. 2006;24: 4991-4997. (Pubitemid 46631401)
17. Park SH, Lee WK, Chung M, et al. Paclitaxel versus docetaxel for advanced gastric cancer: A randomized phase II trial in combination with infusional 5-fluorouracil. Anticancer Drugs. 2006;17:225-229.
18. Lee HJ, Cho do Y, Park JC, et al. Phase II trial of biweekly paclitaxel plus infusional 5-fluorouracil and leucovorin in patients with advanced or recurrent inoperable gastric cancer. Cancer Chemother Pharmacol. 2009; 63:427-432.
19. Im CK, Jeung HC, Rha SY, et al. A phase II study of paclitaxel combined with infusional 5-fluorouracil and low-dose leucovorin for advanced gastric cancer. Cancer Chemother Pharmacol. 2008;61:315-321. (Pubitemid 350160330)
20. Ninomiya M, Kondo K, Matsuo K, et al. Multicenter phase II trial of combination chemotherapy with weekly paclitaxel and 5-fluorouracil for the treatment of advanced or recurrent gastric carcinoma. J Chemother. 2007;9:444-450. (Pubitemid 47240953)
21. Cho BC, Kim JH, Kim CB, et al. Paclitaxel and leucovorin-modulated infusional 5-fluorouracil combination chemotherapy for metastatic gastric cancer. Oncol Rep. 2006;15:621-627.
22. Yeh KH, Lu YS, Hsu CH, et al. Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer. Oncology. 2005;69:88-95.
23. Murad AM, Petroianu A, Guimaraes RC, et al. Phase II trial of the combination of paclitaxel and 5-fluorouracil in the treatment of advanced gastric cancer: A novel, safe, and effective regimen. Am J Clin Oncol. 1999;22:580-586. (Pubitemid 30266056)
24. Bokemeyer C, Lampe CS, Clemens MR, et al. A phase II trial of paclitaxel and weekly 24 h infusion of 5-fluorouracil/folinic acid in patients with advanced gastric cancer. Anticancer Drugs. 1997;8:396-399. (Pubitemid 27204960)
25. Sakamoto J, Matsui T, Kodera Y. Paclitaxel chemotherapy for the treatment of gastric cancer. Gastric Cancer. 2009;12:69-78.